Pharma Reaserch (Korea) Technical Analysis
| 214450 Stock | KRW 251,000 500.00 0.20% |
As of the 11th of January 2025, Pharma Reaserch holds the Risk Adjusted Performance of 0.0787, semi deviation of 2.57, and Coefficient Of Variation of 1154.79. Our technical analysis interface allows you to check existing technical drivers of Pharma Reaserch Prod, as well as the relationship between them.
Pharma Reaserch Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Pharma, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PharmaPharma |
Pharma Reaserch technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Pharma Reaserch Prod Technical Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Pharma Reaserch Prod volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Pharma Reaserch Prod Trend Analysis
Use this graph to draw trend lines for Pharma Reaserch Prod. You can use it to identify possible trend reversals for Pharma Reaserch as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Pharma Reaserch price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Pharma Reaserch Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Pharma Reaserch Prod applied against its price change over selected period. The best fit line has a slop of 652.11 , which means Pharma Reaserch Prod will continue producing value for investors. It has 122 observation points and a regression sum of squares at 1.608285837758E10, which is the sum of squared deviations for the predicted Pharma Reaserch price change compared to its average price change.About Pharma Reaserch Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Pharma Reaserch Prod on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Pharma Reaserch Prod based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Pharma Reaserch Prod price pattern first instead of the macroeconomic environment surrounding Pharma Reaserch Prod. By analyzing Pharma Reaserch's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Pharma Reaserch's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Pharma Reaserch specific price patterns or momentum indicators. Please read more on our technical analysis page.
Pharma Reaserch January 11, 2025 Technical Indicators
Most technical analysis of Pharma help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Pharma from various momentum indicators to cycle indicators. When you analyze Pharma charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0787 | |||
| Market Risk Adjusted Performance | 3.41 | |||
| Mean Deviation | 2.52 | |||
| Semi Deviation | 2.57 | |||
| Downside Deviation | 2.79 | |||
| Coefficient Of Variation | 1154.79 | |||
| Standard Deviation | 3.39 | |||
| Variance | 11.51 | |||
| Information Ratio | 0.0871 | |||
| Jensen Alpha | 0.2848 | |||
| Total Risk Alpha | 0.3326 | |||
| Sortino Ratio | 0.1061 | |||
| Treynor Ratio | 3.4 | |||
| Maximum Drawdown | 16.81 | |||
| Value At Risk | (5.25) | |||
| Potential Upside | 5.83 | |||
| Downside Variance | 7.76 | |||
| Semi Variance | 6.6 | |||
| Expected Short fall | (3.17) | |||
| Skewness | 0.9878 | |||
| Kurtosis | 2.48 |
Complementary Tools for Pharma Stock analysis
When running Pharma Reaserch's price analysis, check to measure Pharma Reaserch's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharma Reaserch is operating at the current time. Most of Pharma Reaserch's value examination focuses on studying past and present price action to predict the probability of Pharma Reaserch's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharma Reaserch's price. Additionally, you may evaluate how the addition of Pharma Reaserch to your portfolios can decrease your overall portfolio volatility.
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities |